This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Croft, D. R. Articles by Olson, M. F. Search for Related Content PubMed PubMed Citation Articles by Croft, D. R. Articles by Olson, M. F.

Conditional ROCK Activation In vivo Induces Tumor Cell Dissemination and Angiogenesis

¹ Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; ² Cancer Research UK London Research Institute, London, United Kingdom; ³ The Institute of Cancer Research, London, United Kingdom; and ⁴ Department of Medicine and Cancer Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Progression of tumors to invasive and metastatic forms requires that tumor cells undergo dramatic morphologic changes, a process regulated by Rho GTPases. Elevated expression of RhoA and RhoC, as well as the Rho effector proteins ROCK I and ROCK II, are commonly observed in human cancers and are often associated with more invasive and metastatic phenotypes. To examine how ROCK contributes to the progression of solid tumors, we established a conditionally activated form of ROCK II by fusing the kinase domain to the estrogen receptor hormone-binding domain (ROCK:ER). ROCK:ER-expressing colon carcinoma cells grown as tumors in immunocompromised nude mice organized into discrete clusters surrounding blood vessels. However, ROCK:ER activation resulted in the aggressive dissemination of tumor cells into the surrounding stroma, indicating that increased ROCK signaling is sufficient to promote invasion from solid tumors. In addition, tumors in which ROCK:ER was activated were more highly vascularized, indicating that ROCK contributes to tumor angiogenesis. ROCK:ER activation resulted in changes to epithelial morphology and organization that facilitated motility in vitro, likely by inducing the redistribution of proteins such as ezrin, as well as adherens junction and extracellular matrix-binding proteins. These results suggest that ROCK inhibitors would be useful antimetastatic and antiangiogenic chemotherapeutic agents in tumors associated with elevated RhoA, RhoC, ROCK I, or ROCK II expression.

This article has been cited by other articles:

				H. N. Woodward, A. Anwar, S. Riddle, L. Taraseviciene-Stewart, M. Fragoso, K. R. Stenmark, and E. V. Gerasimovskaya PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L954 - L964. [Abstract] [Full Text] [PDF]

				N. Okumura, M. Ueno, N. Koizumi, Y. Sakamoto, K. Hirata, J. Hamuro, and S. Kinoshita Enhancement on Primate Corneal Endothelial Cell Survival In Vitro by a ROCK Inhibitor Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3680 - 3687. [Abstract] [Full Text] [PDF]

				R. Strauss, P. Sova, Y. Liu, Z. Y. Li, S. Tuve, D. Pritchard, P. Brinkkoetter, T. Moller, O. Wildner, S. Pesonen, et al. Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses Cancer Res., June 15, 2009; 69(12): 5115 - 5125. [Abstract] [Full Text] [PDF]

				B. Joshi, S. S. Strugnell, J. G. Goetz, L. D. Kojic, M. E. Cox, O. L. Griffith, S. K. Chan, S. J. Jones, S.-P. Leung, H. Masoudi, et al. Phosphorylated Caveolin-1 Regulates Rho/ROCK-Dependent Focal Adhesion Dynamics and Tumor Cell Migration and Invasion Cancer Res., October 15, 2008; 68(20): 8210 - 8220. [Abstract] [Full Text] [PDF]

				P. A. Singleton, J. G.N. Garcia, and J. Moss Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis Mol. Cancer Ther., June 1, 2008; 7(6): 1669 - 1679. [Abstract] [Full Text] [PDF]

				M. Schiappacassi, F. Lovat, V. Canzonieri, B. Belletti, S. Berton, D. Di Stefano, A. Vecchione, A. Colombatti, and G. Baldassarre p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis Mol. Cancer Ther., May 1, 2008; 7(5): 1164 - 1175. [Abstract] [Full Text] [PDF]

				M. Kim, H.-R. Jang, J.-H. Kim, S.-M. Noh, K.-S. Song, J.-S. Cho, H.-Y. Jeong, J. C. Norman, P. T. Caswell, G. H. Kang, et al. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion Carcinogenesis, March 1, 2008; 29(3): 629 - 637. [Abstract] [Full Text] [PDF]

				J. Chen, E. Guerriero, K. Lathrop, and N. SundarRaj Rho/ROCK Signaling in Regulation of Corneal Epithelial Cell Cycle Progression Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 175 - 183. [Abstract] [Full Text] [PDF]

				E. Sahai, R. Garcia-Medina, J. Pouyssegur, and E. Vial Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility J. Cell Biol., January 1, 2007; 176(1): 35 - 42. [Abstract] [Full Text] [PDF]

				Y.-W. E. Chang, J. W. Marlin, T. W. Chance, and R. Jakobi RhoA Mediates Cyclooxygenase-2 Signaling to Disrupt the Formation of Adherens Junctions and Increase Cell Motility Cancer Res., December 15, 2006; 66(24): 11700 - 11708. [Abstract] [Full Text] [PDF]

				J. Sturge, D. Wienke, and C. M. Isacke Endosomes generate localized Rho-ROCK-MLC2-based contractile signals via Endo180 to promote adhesion disassembly J. Cell Biol., October 23, 2006; 175(2): 337 - 347. [Abstract] [Full Text] [PDF]

				H. Lu, K. L. Knutson, E. Gad, and M. L. Disis The Tumor Antigen Repertoire Identified in Tumor-Bearing Neu Transgenic Mice Predicts Human Tumor Antigens Cancer Res., October 1, 2006; 66(19): 9754 - 9761. [Abstract] [Full Text] [PDF]

				F. E. Turner, S. Broad, F. L. Khanim, A. Jeanes, S. Talma, S. Hughes, C. Tselepis, and N. A. Hotchin Slug Regulates Integrin Expression and Cell Proliferation in Human Epidermal Keratinocytes J. Biol. Chem., July 28, 2006; 281(30): 21321 - 21331. [Abstract] [Full Text] [PDF]

				D. R. Croft and M. F. Olson The Rho GTPase Effector ROCK Regulates Cyclin A, Cyclin D1, and p27Kip1 Levels by Distinct Mechanisms Mol. Cell. Biol., June 15, 2006; 26(12): 4612 - 4627. [Abstract] [Full Text] [PDF]

				H. J. Spence, L. McGarry, C. S. Chew, N. O. Carragher, L. A. Scott-Carragher, Z. Yuan, D. R. Croft, M. F. Olson, M. Frame, and B. W. Ozanne AP-1 Differentially Expressed Proteins Krp1 and Fibronectin Cooperatively Enhance Rho-ROCK-Independent Mesenchymal Invasion by Altering the Function, Localization, and Activity of Nondifferentially Expressed Proteins Mol. Cell. Biol., February 15, 2006; 26(4): 1480 - 1495. [Abstract] [Full Text] [PDF]

				Z. Jia, L. Barbier, H. Stuart, M. Amraei, S. Pelech, J. W. Dennis, P. Metalnikov, P. O'Donnell, and I. R. Nabi Tumor Cell Pseudopodial Protrusions: LOCALIZED SIGNALING DOMAINS COORDINATING CYTOSKELETON REMODELING, CELL ADHESION, GLYCOLYSIS, RNA TRANSLOCATION, AND PROTEIN TRANSLATION J. Biol. Chem., August 26, 2005; 280(34): 30564 - 30573. [Abstract] [Full Text] [PDF]

				Z. N. Demou, M. Awad, T. McKee, J. Y. Perentes, X. Wang, L. L. Munn, R. K. Jain, and Y. Boucher Lack of Telopeptides in Fibrillar Collagen I Promotes the Invasion of a Metastatic Breast Tumor Cell Line Cancer Res., July 1, 2005; 65(13): 5674 - 5682. [Abstract] [Full Text] [PDF]

				D. R. Croft, M. L. Coleman, S. Li, D. Robertson, T. Sullivan, C. L. Stewart, and M. F. Olson Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration J. Cell Biol., January 17, 2005; 168(2): 245 - 255. [Abstract] [Full Text] [PDF]